Shu-Feng Zhou

2.7k citations
39 papers · 1.9k indexed · 1 hit paper · h-index 21

Shu-Feng Zhou

39 papers receiving 1.9k citations

Hit Papers

Historical Perspective of Traditional Indigenous Medical ...3472014202620182022100200300

Peers

Shu-Feng Zhou
Comparison fields: 5 of 149
  • Pharmacology 489
  • Complementary and alternative medicine 153
  • Toxicology 52
  • Rehabilitation 87
  • Biochemistry 74
Replace Pallab Maity with:
Pallab Maity Germany
Samik Bindu India
Tomonori Nakamura Japan
Patrick Bouic South Africa
Hong Ding China
Chang‐Gue Son South Korea
Sérgio M. Borghi Brazil
Kyung‐Seop Ahn South Korea
Shakir Ali India
Midori Hirai Japan
Shu-Feng Zhou relative to Pallab Maity Germany Pallab Maity's profile →
Citations per field
00.5×1.5×2.3×
Pallab Maity · 1×
Citations per year

Countries citing papers authored by Shu-Feng Zhou

Since Specialization
Citations

This map shows the geographic impact of Shu-Feng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-Feng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-Feng Zhou more than expected).

Fields of papers citing papers by Shu-Feng Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu-Feng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-Feng Zhou. The network helps show where Shu-Feng Zhou may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shu-Feng Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shu-Feng Zhou Line = papers co-authored together Shu-Feng Zhou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201740
2 201710
3 20176
4 201639
5 201436
6 201417
7 201411
8 20142
9 20133
10 201115
11 201120
12
The Future of Traditional Chinese Medicine
20091
13 200989
14 200968
15 20081
16 200833
17 2008119
18 200733
19 20076
20 2006139

About Shu-Feng Zhou

Shu-Feng Zhou is a scholar working on Biochemistry, Pharmacology and Rehabilitation, having authored 39 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Inflammatory mediators and NSAID effects (3 papers), Folate and B Vitamins Research (3 papers), Stroke Rehabilitation and Recovery (2 papers), Nitric Oxide and Endothelin Effects (2 papers), RNA Interference and Gene Delivery (2 papers) and Pancreatitis Pathology and Treatment (2 papers). The work is most often cited by research in Pharmacology (489 citations), Complementary and alternative medicine (153 citations) and Toxicology (52 citations). Shu-Feng Zhou has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yinxue Yang, Zhi‐Ling Yu, Kam‐Ming Ko, Si-Yuan Pan, Yanyang Wang, Hong Zhe, Zhixu He, Minke Tang, Gao S and Shuofeng Zhang. Their work appears in journals such as Molecules, Critical Reviews in Food Science and Nutrition and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026